BB Biotech AG (BBAGF)
BB Biotech AG operates in the Asset Management industry of the Financial Services sector, headquartered in Kusnacht, CH. The stock last traded at $55.00, down 27.69% on the session, giving a market capitalisation of $4.22B. On trailing twelve-month figures it carries a trailing P/E of 2.20, a net margin of 924.0%. Its beta of 0.57 implies it has historically moved less than the broad market.
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.
BB Biotech AG is most often compared with the following Financial Services names: